Literature DB >> 12215886

Replication competent helper functions for recombinant AAV vector generation.

L Cao1, M During, W Xiao.   

Abstract

Adeno-associated virus (AAV) is a promising gene transfer vector tested in both animal studies and human clinical trials. However, current production methods are generally inefficient and require improvements to meet the increasing clinical need for economical, high titer and high quality rAAV vectors. The inefficiency of the current systems largely arises from the AAV helper function, which contains only the AAV coding region but lacks inverted terminal repeats. The terminal repeats were originally removed to prevent replication competent AAV contamination. Here we designed a novel and highly efficient rAAV helper function containing AAV terminal repeats. The new helper function not only mimics the wild-type AAV growth as it replicates along with the vector plasmid, but also restores the cis regulating function of the AAV terminal repeats. Addition of heterologous introns to the helper genome and use of a mutant AAV terminal repeat defective in packaging effectively controls the contamination of replication competent AAV particles. This new strategy also performs better in AAV producing cell lines than those based on non-replicating AAV rep and cap genome.

Entities:  

Mesh:

Year:  2002        PMID: 12215886      PMCID: PMC2638078          DOI: 10.1038/sj.gt.3301710

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  55 in total

1.  Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.

Authors:  J Y Dong; P D Fan; R A Frizzell
Journal:  Hum Gene Ther       Date:  1996-11-10       Impact factor: 5.695

2.  High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

Authors:  J E Conway; C M Rhys; I Zolotukhin; S Zolotukhin; N Muzyczka; G S Hayward; B J Byrne
Journal:  Gene Ther       Date:  1999-06       Impact factor: 5.250

3.  Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products.

Authors:  K A Vincent; S T Piraino; S C Wadsworth
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  A novel packaging system for the generation of helper-free oncolytic MVM vector stocks.

Authors:  A Brandenburger; S Russell
Journal:  Gene Ther       Date:  1996-10       Impact factor: 5.250

5.  A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

Authors:  R J Parks; L Chen; M Anton; U Sankar; M A Rudnicki; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.

Authors:  K R Clark; F Voulgaropoulou; P R Johnson
Journal:  Gene Ther       Date:  1996-12       Impact factor: 5.250

7.  A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle.

Authors:  X Xiao; W Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.

Authors:  S Muramatsu; H Mizukami; N S Young; K E Brown
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

9.  A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography.

Authors:  K Tamayose; Y Hirai; T Shimada
Journal:  Hum Gene Ther       Date:  1996-03-01       Impact factor: 5.695

View more
  8 in total

1.  Improved splicing of adeno-associated viral (AAV) capsid protein-supplying pre-mRNAs leads to increased recombinant AAV vector production.

Authors:  K David Farris; David J Pintel
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

Review 2.  Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.

Authors:  Sumit Ghosh; Alex M Brown; Chris Jenkins; Katie Campbell
Journal:  Appl Biosaf       Date:  2020-03-01

3.  Characterization of genome integrity for oversized recombinant AAV vector.

Authors:  Biao Dong; Hiroyuki Nakai; Weidong Xiao
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

Review 4.  Gene delivery with viral vectors for cerebrovascular diseases.

Authors:  Yu Gan; Zheng Jing; Ruth Anne Stetler; Guodong Cao
Journal:  Front Biosci (Elite Ed)       Date:  2013-01-01

5.  Development of a Novel Recombinant Adeno-Associated Virus Production System Using Human Bocavirus 1 Helper Genes.

Authors:  Zekun Wang; Fang Cheng; John F Engelhardt; Ziying Yan; Jianming Qiu
Journal:  Mol Ther Methods Clin Dev       Date:  2018-10-04       Impact factor: 6.698

6.  Developing an Anion Exchange Chromatography Assay for Determining Empty and Full Capsid Contents in AAV6.2.

Authors:  Chunlei Wang; Sri Hari Raju Mulagapati; Zhongying Chen; Jing Du; Xiaohui Zhao; Guoling Xi; Liyan Chen; Thomas Linke; Cuihua Gao; Albert E Schmelzer; Dengfeng Liu
Journal:  Mol Ther Methods Clin Dev       Date:  2019-09-26       Impact factor: 6.698

7.  Systematic Comparison and Validation of Quantitative Real-Time PCR Methods for the Quantitation of Adeno-Associated Viral Products.

Authors:  Natalie Jayne Werling; Stifani Satkunanathan; Robin Thorpe; Yuan Zhao
Journal:  Hum Gene Ther Methods       Date:  2015-06-09       Impact factor: 2.396

8.  Vaccinia virus as a subhelper for AAV replication and packaging.

Authors:  Andrea R Moore; Biao Dong; Lingxia Chen; Weidong Xiao
Journal:  Mol Ther Methods Clin Dev       Date:  2015-11-18       Impact factor: 6.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.